Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan A Grupp

Showing results (21-30 of 238) with videos related to

Pageof 24
Sort By:
Current Opinion in Pediatrics|December 24, 2013
Toxicity management for patients receiving novel T-cell engaging therapiesDavid M Barrett, David T Teachey, Stephan A Grupp
British Journal of Haematology|April 7, 2009
Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignanciesDavid T Teachey, Stephan A Grupp, Valerie I Brown
Science Translational Medicine|January 8, 2016
Early memory phenotypes drive T cell proliferation in patients with pediatric malignanciesNathan Singh, Jessica Perazzelli, Stephan A Grupp, et al.
Cancer Journal (Sudbury, Mass.)|March 22, 2021
Improving and Maintaining Responses in Pediatric B-Cell Acute Lymphoblastic Leukemia Chimeric Antigen Receptor-T Cell TherapyRahul Arya, David M Barrett, Stephan A Grupp, et al.
Cancer Journal (Sudbury, Mass.)|March 27, 2014
Managing cytokine release syndrome associated with novel T cell-engaging therapiesShannon L Maude, David Barrett, David T Teachey, et al.
Current Treatment Options in Oncology|April 22, 2016
CAR T Cell Therapy in Acute Lymphoblastic Leukemia and Potential for Chronic Lymphocytic LeukemiaNathan Singh, Noelle V Frey, Stephan A Grupp, et al.
Pediatric Blood & Cancer|January 24, 2006
Collection, storage, and infusion of stem cells in children with high-risk neuroblastoma: saving for a rainy dayStephan A Grupp, Susan L Cohn, Donna Wall, et al.
Cytotherapy|July 6, 2020
Thoracic duct lymphatic fluid harbors phenotypically naive T cells for use in adoptive T-cell therapyJessica B Foster, Yoav Dori, Stephan A Grupp, et al.
Paediatric Drugs|August 1, 2012
Targeting the PI3K/AKT/mTOR signaling axis in children with hematologic malignanciesDavid Barrett, Valerie I Brown, Stephan A Grupp, et al.
Cancer Discovery|January 12, 2019
Naïve T-cell Deficits at Diagnosis and after Chemotherapy Impair Cell Therapy Potential in Pediatric CancersRajat K Das, Lauren Vernau, Stephan A Grupp, et al.
Pageof 24

Showing results (21-30 of 238) with videos related to

Sort By:
Pageof 24
Current Opinion in Pediatrics|December 24, 2013
Toxicity management for patients receiving novel T-cell engaging therapiesDavid M Barrett, David T Teachey, Stephan A Grupp
British Journal of Haematology|April 7, 2009
Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignanciesDavid T Teachey, Stephan A Grupp, Valerie I Brown
Science Translational Medicine|January 8, 2016
Early memory phenotypes drive T cell proliferation in patients with pediatric malignanciesNathan Singh, Jessica Perazzelli, Stephan A Grupp, et al.
Cancer Journal (Sudbury, Mass.)|March 22, 2021
Improving and Maintaining Responses in Pediatric B-Cell Acute Lymphoblastic Leukemia Chimeric Antigen Receptor-T Cell TherapyRahul Arya, David M Barrett, Stephan A Grupp, et al.
Cancer Journal (Sudbury, Mass.)|March 27, 2014
Managing cytokine release syndrome associated with novel T cell-engaging therapiesShannon L Maude, David Barrett, David T Teachey, et al.
Current Treatment Options in Oncology|April 22, 2016
CAR T Cell Therapy in Acute Lymphoblastic Leukemia and Potential for Chronic Lymphocytic LeukemiaNathan Singh, Noelle V Frey, Stephan A Grupp, et al.
Pediatric Blood & Cancer|January 24, 2006
Collection, storage, and infusion of stem cells in children with high-risk neuroblastoma: saving for a rainy dayStephan A Grupp, Susan L Cohn, Donna Wall, et al.
Cytotherapy|July 6, 2020
Thoracic duct lymphatic fluid harbors phenotypically naive T cells for use in adoptive T-cell therapyJessica B Foster, Yoav Dori, Stephan A Grupp, et al.
Paediatric Drugs|August 1, 2012
Targeting the PI3K/AKT/mTOR signaling axis in children with hematologic malignanciesDavid Barrett, Valerie I Brown, Stephan A Grupp, et al.
Cancer Discovery|January 12, 2019
Naïve T-cell Deficits at Diagnosis and after Chemotherapy Impair Cell Therapy Potential in Pediatric CancersRajat K Das, Lauren Vernau, Stephan A Grupp, et al.
Pageof 24